Olga Millán

About me

Featured publications

• Getting immunosuppression just right: the role of clinical biomarkers in predicting patient response post solid organ transplantation

  Authors:

  Brunet, M; Millán, O;

  Reference: Expert Review Of Clinical Pharmacology 2021.

• Advantages of plasmatic CXCL-10 as a prognostic and diagnostic biomarker for the risk of rejection and subclinical rejection in kidney transplantation

  Authors:

  Millán, O; Espinosa, C; Brunet, M; Rovira, J; Diekmann, F;

  Guirado, L; Budde, K; Sommerer, C; Piñeiro, GJ.

  Reference: Clinical Immunology 2021.

• Nuclear factor of activated T cells as potential pharmacodynamic biomarker for the risk of acute and subclinical rejection in de novo liver recipients

  Authors:

  Millan, Olga; Ruiz, Pablo; Fortuna, Virginia; Navasa, Miquel; Brunet, Merce;

  Reference: Liver International 2020.

• MONITORING OF MIRNA-181A-5P AND MIRNA-155-5P PLASMATIC EXPRESSION AS PROGNOSTIC BIOMARKERS FOR ACUTE AND SUBCLINICAL REJECTION IN DE NOVO ADULT LIVER TRANSPLANT RECIPIENTS

  Authors:

  Millan, Olga; Ruiz, Pablo; Orts, Lara; Ferre, Paula; Crespo, Gonzalo;

  Santana, Miguel; Fortuna, Virginia; Quintairos, Luis; Navasa, Miquel; Brunet, Merce.

  Reference: Transplant International 2019.

• Therapeutic Drug Monitoring of Tacrolimus-Personalized Therapy: Second Consensus Report

  Authors:

  Brunet, Merce; van Gelder, Teun; Asberg, Anders; Haufroid, Vincent; Hesselink, Dennis A;

  (...)

  Sommerer, Claudia; Vethe, Nils Tore; de Winter, Brenda; Christians, Uwe; Bergan, Stein.

  See complete list of authors

  Reference: Therapeutic Drug Monitoring 2019.

• Monitoring of miR-181a-5p and miR-155-5p Plasmatic Expression as Prognostic Biomarkers for Acute and Subclinical Rejection in de novo Adult Liver Transplant Recipients

  Authors:

  Millan, Olga; Ruiz, Pablo; Orts, Lara; Ferre, Paula; Crespo, Gonzalo;

  Santana, Miguel; Fortuna, Virginia; Quintairos, Luis; Navasa, Miguel; Brunet, Merce.

  Reference: Frontiers In Immunology 2019.

• Urinary miR-155-5p and CXCL10 as prognostic and predictive biomarkers of rejection, graft outcome and treatment response in kidney transplantation.

  Authors:

  Millán O; Budde K; Sommerer C; Aliart I; Rissling O;

  (...)

  Matz M; Zeier M; Silva I; Guirado L; Brunet M .

  See complete list of authors

  Reference: British Journal Of Clinical Pharmacology 2017.

• Cytokine-based immune monitoring

  Authors:

  Millan, O.; Brunet, M.;;

  Reference: Clinical Biochemistry 2016.

• Barcelona consensus on biomarker-based immunosuppressive drugs management in solid organ transplantation

  Authors:

  Brunet M; Shipkova M; Van Gelder T; Wieland E; Sommerer C;

  (...)

  Hesselink D; Noceti O; Pawinski T; Wallemacq P; Oellerich M.

  See complete list of authors

  Reference: Therapeutic Drug Monitoring 2016.

• Flow cytometry as platform for biomarker discovery and clinical validation

  Authors:

  Millán O; Brunet M;

  Reference: 2015.

Featured Projects

• Análisis de la expresión de un panel de miRNAs y Quimiocinas como biomarcadores pronóstico precoces del riesgo de rechazo mediado por células T y subclínico post-trasplante hepático

  Principal investigator: Merce Brunet Serra, Olga Millán López

  Code: PI19/00378

  Duration: 01/10/2019 - 31/10/2022

• miRNAs circulantes: Potenciales biomarcadores no invasivos de predicción de rechazo agudo en pacientes trasplantados hepáticos y renales

  Principal investigator: Olga Millán López

  Duration: 01/09/2014 - 30/09/2017

• Evaluación del impacto de la aloreactividad en la evolución del injerto y de la reversibilidad de la fibrosis tras el tratamiento de la hepatitis C post-trasplante hepático

  Principal investigator: MIQUEL NAVASA ANADON, Merce Brunet Serra

  Duration: 01/09/2014 - 30/09/2017

• Estudio del efecto inmunomodulador de la Atorvastatina en trasplante renal: estudios in vitro e in vivo

  Principal investigator: Olga Millán López

  Code: 08/247

  Duration: 01/09/2008 - 30/09/2011

• Estudio multicéntrico para la validación de los biomarcadores de elección que reflejan la respuesta individual de los pacientes trasplantados de órganos sólidos al tratamiento inmunosupresor.

  Principal investigator: Mercedes Brunet Serra

  Code: PI080300

  Duration: 01/09/2008 - 30/09/2011